TY  - JOUR
AU  - Rayego-Mateos, Sandra
AU  - Morgado-Pascual, José Luis
AU  - Opazo-Ríos, Lucas
AU  - Guerrero-Hue, Melania
AU  - García-Caballero, Cristina
AU  - Vázquez-Carballo, Cristina
AU  - Mas, Sebastián
AU  - Sanz, Ana Belén
AU  - Herencia, Carmen
AU  - Mezzano, Sergio
AU  - Gómez-Guerrero, Carmen
AU  - Moreno, Juan Antonio
AU  - Egido, Jesús
PY  - 2020
DO  - 10.3390/ijms21113798
UR  - http://hdl.handle.net/10668/15659
T2  - International journal of molecular sciences
AB  - Diabetic nephropathy (DN) is associated with an increased morbidity and mortality, resulting in elevated cost for public health systems. DN is the main cause of chronic kidney disease (CKD) and its incidence increases the number of patients that...
LA  - en
KW  - and therapy
KW  - chronic kidney disease
KW  - diabetic nephropathy
KW  - drugs
KW  - inflammation
KW  - type 2 diabetes
KW  - Animals
KW  - Anti-Inflammatory Agents
KW  - Diabetic Nephropathies
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Immunosuppressive Agents
TI  - Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.
TY  - research article
VL  - 21
ER  -